The Whole Toolkit Tested in Carotid Artery Stenting

This study sought to randomly compare the double-layer Roadsaver stent (Terumo) with the single-layer Carotid Wallstent device (Boston) in association with either distal filter-like embolic protection device FilterWire (Boston) or proximal protection device Mo.Ma (Medtronic) in patients with lipid-rich carotid plaques.

Por primera vez un estudio confirma que las pantallas de protección plomadas resguardan de la radiación a todo el personal de la sala de cateterismos

This is a very interesting work because there are no head-to-head simultaneous comparisons between these stent types and these brain protection systems: we only had physiopathological speculation.

A total of 104 consecutive patients were randomized to carotid artery stenting with FilterWire + Roadsaver stent (group 1, n = 27), FilterWire + Wallstent (group 2, n = 25), Mo.Ma + Roadsaver stent (group 3, n = 27), or Mo.Ma + Wallstent (group 4, n = 25).

The primary endpoint was the number of microembolic signals on transcranial Doppler in each procedural step: target vessel access; lesion wiring; pre-dilation; stent crossing; stent deployment; post-dilation, and device retrieval.


Read also: Crest-2 Registry: Carotid PCI Presents Low Rates of Death and Stroke.


The Mo.Ma was significantly superior to the FilterWire device in the reduction of microembolic signals (p < 0.0001) during lesion crossing, stent crossing, stent deployment, and post-dilation.

The Roadsaver was significantly superior to the Wallstent device (p = 0.016) during stent deployment and device retrieval. It also reduced the number of spontaneous microembolic signals (29% of patients).

The combination of proximal protection device Mo.Ma and double-layer stent Roadsaver was superior (p = 0.043) to all other combinations.


Read also: New Device for More Protection in Carotid Artery Stenting.


These were the differences found regarding microembolic signals on transcranial Doppler, but there were no clinical differences.

After stenting, peak systolic velocity decreased in all patients. At 6 months, only one patient experienced restenosis.

Conclusion

In patients with high-risk, lipid-rich carotid plaque, angioplasty combining proximal protection device Mo.Ma and double-layer stent Roadsaver resulted in the lowest number of microembolic signals on transcranial Doppler.

Original title: Carotid Wallstent Versus Roadsaver Stent and Distal Versus Proximal Protection on Cerebral Microembolization During Carotid Artery Stenting.

Reference: Piero Montorsi et al. J Am Coll Cardiol Intv 2020;13:403–14.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACC 2026 | HI-PEITHO: Catheter-directed strategy (EKOS) in intermediate-risk acute pulmonary embolism

The treatment of intermediate-risk pulmonary embolism (PE) continues to be an area of therapeutic uncertainty. The initial PEITHO study (2014) demonstrated a reduction in...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...

AHA/ACC Guideline on the Management of Acute Pulmonary Embolism 2026

The 2026 ACC/AHA guideline for the management of acute pulmonary embolism (PE) introduces a conceptual shift by replacing the traditional “risk-based” classification with an...

FFR Assessment for the Selection of Hypertensive Patients Who Benefit from Renal Stenting

Atherosclerotic renal artery stenosis (ARAS) represents one of the main causes of secondary hypertension (HTN) and is associated with a higher risk of renal...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | CHIP-BCIS3: Impella use as support in high-risk complex PCI

The use of percutaneous ventricular support during high-risk complex PCI has been proposed as a strategy to prevent hemodynamic deterioration in patients with severe...

ACC 2026 | ORBITA-CTO: PCI in chronic total occlusions and stable angina — the randomized trial we were missing?

Percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) remains a topic of ongoing debate in stable angina, with persistent uncertainty regarding its role...

ACC 2026 | FAST III: vFFR vs FFR in physiology-guided revascularization of intermediate coronary lesions

Physiological assessment of intermediate coronary lesions remains a cornerstone in decision-making for coronary revascularization. Although FFR continues to be one of the guideline-recommended references,...